Elevance Health CFO Mark Kaye Sells a Third of His Stock at $441 a Share
As seen on the 24/7 Wall St. homepage on October 23, 2026.
Elevance's CFO cut roughly a third of his reported common stock in one day, selling 10,584 shares for about $4.65 million into prices as high as $447.19. No 10b5-1 plan is flagged, which makes this a discretionary exit by the person who knows the Medicare Advantage cost math best.
Continue ReadingShow less
Mark Kaye, the chief financial officer of Elevance Health, sold 10,584 shares on October 23, 2026, about a third of his reported common stock position.
No 10b5-1 plan was flagged alongside the filing, making this a discretionary sale rather than one executed on a pre-arranged schedule.
Sponsored
Twelve Tabs, One Thesis
Your Research Resets Every Morning
The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.
AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.
See What a Built View Looks Like →
(Sponsor)
The timing draws attention because Elevance, like other large managed-care insurers, has been navigating rising medical costs in its Medicare Advantage business. Kaye, as CFO, sits closer to that cost math than virtually anyone else at the company, which is precisely why a discretionary sale of this size warrants close attention from investors watching the stock.
Watch whether additional insiders follow with their own sales, and how Elevance's next earnings report frames Medicare Advantage utilization trends.
Sources
Mentioned: ELV